FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1915511000001106: Maxalt 10mg tablets (Organon Pharma (UK) Ltd) 6 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1746661000001118 Maxalt 10mg tablets (Organon Pharma (UK) Ltd) 6 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1746671000001111 Maxalt 10mg tablets (Organon Pharma (UK) Ltd) 6 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Maxalt 10mg tablets (Organon Pharma (UK) Ltd) 6 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Maxalt 10mg tablets (Organon Pharma (UK) Ltd) 6 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Maxalt 10mg tablets (Organon Pharma (UK) Ltd) 6 tablet Is a Rizatriptan 10mg tablets 6 tablet true Inferred relationship Existential restriction modifier
Maxalt 10mg tablets (Organon Pharma (UK) Ltd) 6 tablet Is pack of Maxalt 10mg tablets (Organon Pharma (UK) Ltd) false Inferred relationship Existential restriction modifier
Maxalt 10mg tablets (Organon Pharma (UK) Ltd) 6 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Maxalt 10mg tablets (Organon Pharma (UK) Ltd) 6 tablet Has active ingredient Rizatriptan benzoate false Inferred relationship Existential restriction modifier
Maxalt 10mg tablets (Organon Pharma (UK) Ltd) 6 tablet Has active ingredient Rizatriptan false Inferred relationship Existential restriction modifier
Maxalt 10mg tablets (Organon Pharma (UK) Ltd) 6 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Maxalt 10mg tablets (Organon Pharma (UK) Ltd) 6 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Maxalt 10mg tablets (Organon Pharma (UK) Ltd) 6 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Maxalt 10mg tablets (Organon Pharma (UK) Ltd) 6 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Maxalt 10mg tablets (Organon Pharma (UK) Ltd) 6 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Maxalt 10mg tablets (Organon Pharma (UK) Ltd) 6 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Maxalt 10mg tablets (Organon Pharma (UK) Ltd) 6 tablet Has AMP Maxalt 10mg tablets (Organon Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Maxalt 10mg tablets (Organon Pharma (UK) Ltd) 6 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Rizatriptan true Inferred relationship Existential restriction modifier
Maxalt 10mg tablets (Organon Pharma (UK) Ltd) 6 tablet Has specific active ingredient Rizatriptan benzoate true Inferred relationship Existential restriction modifier
Maxalt 10mg tablets (Organon Pharma (UK) Ltd) 6 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Maxalt 10mg tablets (Organon Pharma (UK) Ltd) 6 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Maxalt 10mg tablets (Organon Pharma (UK) Ltd) 6 tablet Has basis of strength substance Rizatriptan true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start